Race, Kidney Disease Progression, and Mortality Risk in HIV-Infected Persons
Open Access
- 1 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 5 (12) , 2269-2275
Abstract
Background and objectives: The burden of HIV-associated chronic kidney disease (CKD) is growing in the United States, partially because of increased HIV-infection rates among African Americans. We determined the prevalence, incidence, and risk of rapid estimated GFR (eGFR) decline, ESRD, and death among HIV-infected (HIV+) African-American and non–African-American individuals cared for at the Comprehensive Care Center in Nashville, Tennessee, from January 1, 1998, through December 31, 2005. Design, setting, participants, & measurements: Mixed effects, competing risks, and Poisson and Cox regression models were used to assess the risk of rapid eGFR decline (defined as ≥50% decrease in baseline eGFR), CKD5/ESRD, and death. The Chronic Kidney Disease Epidemiology Collaboration equation was used to calculate eGFR. Confounders were adjusted with a propensity score that related patient characteristics to the probability of being African American. Mixed effects models compared the rate of rapid eGFR decline for HIV-infected African Americans and non–African Americans. Results: There were 2468 HIV-infected individuals in the study: 33% African American; 21% female. Among all patients, HIV-infected African Americans did not have a statistically significant increased risk for rapid eGFR decline compared with non–African Americans. However, African Americans had a significantly higher risk of ESRD and tended toward a higher risk of death. Conclusions: HIV-infected African Americans did not have a statistically significant difference in the risk of eGFR decline when compared with HIV-infected non–African Americans. The findings in this study have potential public health significance.Keywords
This publication has 17 references indexed in Scilit:
- Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African AmericansKidney International, 2009
- Racial Differences in Mortality Among Those with CKDJournal of the American Society of Nephrology, 2008
- Chronic Kidney Disease Incidence, and Progression to End‐Stage Renal Disease, in HIV‐Infected Individuals: A Tale of Two RacesThe Journal of Infectious Diseases, 2008
- Racial Differences in End-Stage Renal Disease Rates in HIV Infection versus DiabetesJournal of the American Society of Nephrology, 2007
- United States Renal Data System 2006 Annual Data Report AbstractAmerican Journal of Kidney Diseases, 2007
- Predicting initiation and progression of chronic kidney disease: Developing renal risk scoresKidney International, 2006
- Highly Active Antiretroviral Therapy and the Epidemic of HIV+ End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2005
- Is There an Epidemic of HIV Infection in the US ESRD Program?Journal of the American Society of Nephrology, 2004
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999